Integrated Biopharma (INBP) 0.0850 $INBP
Global Market Study on Botanical Supplements 2014-2020 - Personal Care Segment to Witness Highest Growth in the $90 Billion Market
M2 - Wed Jul 08, 8:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mpw8qb/global_market) has announced the addition of the "Global Market Study on Botanical Supplements: Personal Care Segment to Witness Highest Growth by 2020" report to their offering. The global market for botanical supplements in value term grew from USD 45.1 billion in 2010 to USD 54.6 billion in 2013, and is expected to grow to USD 90.2 billion in 2020 growing at a CAGR of 7.5%. Also, Usage of botanical supplements by adult women (largest end user in 2013) is projected to increase to USD 32.9 billion in 2020 at a CAGR of 7.5%. Interest in healthy eating is influencing consumers to shift their dietary preferences in favour of food and food ingredients with potential health benefits. For consumers looking for a healthy lifestyle and seeking to reduce the risk of illness, herbal and botanical supplements (popularly known as herbal medicinal products) are among the best options. Botanical supplements include fresh or dried products in different forms, such as tablets, capsules, powders, and tea bags. Globally, garlic, ginger, santalum, plantago, ginseng, rhodiola extract, red clover extract, and soy extract are some of the most widely used botanical supplements. Increasing elderly population and little or no side effects of botanical supplements are expected to drive the global botanical supplements market. According to the Population Division of the United Nations Department of Economic and Social Affairs (UN-DESA), there were 841 million people aged 60 and above in 2013 compared to 205 million in 1950. The number is projected to reach over 2 billion by 2050. In the last few years, Europe has emerged as the largest market for botanical supplements, followed by Asia Pacific. In Asia Pacific, the long-standing tradition of using botanical medicine, the current economic development, and increasing urbanization are some factors driving the increasing demand for botanical supplements. Owing to these factors, Asia Pacific is expected to surpass Europe as the leading market for botanical supplements. The botanical supplements market is fragmented with several players operating at global or regional levels. The global botanical supplements market is highly fragmented, with top eight companies holding less than 40% market share. Ricola and Procter & Gamble are some of the major companies with global operations. Dabur operates mostly in India; however, the company started selling its products in the North American and European countries, such as the U.S., France, Germany and the U.K., recently. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porters Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Market Size and Forecast, by Application Chapter 6 Market Size and Forecast, by End User Chapter 7 Market Size and Forecast, by Geography Chapter 8 Competitive Scenario Chapter 9 Company Profiles - BASF SE - Bayer AG - Bio-Botanica Inc. - Blackmores Limited - ChromaDex, Inc. - Integrated BioPharma, Inc. - NBTY, Inc. - NaturaLife Asia Co., Ltd. - Nutraceutical International Corporation - Pharmavite LLC - Procter & Gamble Company - Ricola AG - Surya Herbal, Ltd. - The Himalaya Drug Company For more information visit http://www.researchandmarkets.com/research/mp...bal_market
NUTR: 24.49 (+0.25), PG: 80.95 (+0.29)
Global Paclitaxel Industry Report 2015
M2 - Fri Jan 09, 6:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/p5l2qc/global_paclitaxel) has announced the addition of the "Global Paclitaxel Industry Report 2015" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Paclitaxel market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Paclitaxel industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on Paclitaxel industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Paclitaxel industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: Chapter One Paclitaxel Industry Overview Chapter Two Paclitaxel International and China Market Analysis Chapter Three Paclitaxel Technical Data and Manufacturing Plants Analysis Chapter Four Paclitaxel Production by Regions by Technology by Applications Chapter Five Paclitaxel Manufacturing Process and Cost Structure Chapter Six 2009-2014 Paclitaxel Productions Supply Sales Demand Market Status and Forecast Chapter Seven Paclitaxel Key Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis Chapter Nine Paclitaxel Marketing Channels Analysis Chapter Ten 2015-2020 Paclitaxel Productions Supply Sales Demand Market Status and Forecast Chapter Eleven Paclitaxel Industry Development Proposals Chapter Twelve Paclitaxel New Project Investment Feasibility Analysis Chapter Thirteen Global and China Paclitaxel Industry Research Conclusions Companies Mentioned - Chongqin Meilian - Haiyao - Huiang - Jiangsu Yew Pharmaceutical Co, Ltd - Just From Natural - Sichuan Jiufeng - South Pharmaceutical - Taiji - Yunnan Hande Bio-Tech Co.,Ltd - Atlantis Bioactives - Indena - Mayne(Hospira) - Npi - Paxis(Integrated Biopharma) - Phyton - Phytogen - Roche Group - Weyerhaeser For more information visit http://www.researchandmarkets.com/research/p5...paclitaxel
Global Market Study on Botanical Supplements 2014-2020 - Personal Care Segment to Witness Highest Growth in the $90 Billion Market
M2 - Wed Jul 08, 8:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mpw8qb/global_market) has announced the addition of the "Global Market Study on Botanical Supplements: Personal Care Segment to Witness Highest Growth by 2020" report to their offering. The global market for botanical supplements in value term grew from USD 45.1 billion in 2010 to USD 54.6 billion in 2013, and is expected to grow to USD 90.2 billion in 2020 growing at a CAGR of 7.5%. Also, Usage of botanical supplements by adult women (largest end user in 2013) is projected to increase to USD 32.9 billion in 2020 at a CAGR of 7.5%. Interest in healthy eating is influencing consumers to shift their dietary preferences in favour of food and food ingredients with potential health benefits. For consumers looking for a healthy lifestyle and seeking to reduce the risk of illness, herbal and botanical supplements (popularly known as herbal medicinal products) are among the best options. Botanical supplements include fresh or dried products in different forms, such as tablets, capsules, powders, and tea bags. Globally, garlic, ginger, santalum, plantago, ginseng, rhodiola extract, red clover extract, and soy extract are some of the most widely used botanical supplements. Increasing elderly population and little or no side effects of botanical supplements are expected to drive the global botanical supplements market. According to the Population Division of the United Nations Department of Economic and Social Affairs (UN-DESA), there were 841 million people aged 60 and above in 2013 compared to 205 million in 1950. The number is projected to reach over 2 billion by 2050. In the last few years, Europe has emerged as the largest market for botanical supplements, followed by Asia Pacific. In Asia Pacific, the long-standing tradition of using botanical medicine, the current economic development, and increasing urbanization are some factors driving the increasing demand for botanical supplements. Owing to these factors, Asia Pacific is expected to surpass Europe as the leading market for botanical supplements. The botanical supplements market is fragmented with several players operating at global or regional levels. The global botanical supplements market is highly fragmented, with top eight companies holding less than 40% market share. Ricola and Procter & Gamble are some of the major companies with global operations. Dabur operates mostly in India; however, the company started selling its products in the North American and European countries, such as the U.S., France, Germany and the U.K., recently. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porters Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Market Size and Forecast, by Application Chapter 6 Market Size and Forecast, by End User Chapter 7 Market Size and Forecast, by Geography Chapter 8 Competitive Scenario Chapter 9 Company Profiles - BASF SE - Bayer AG - Bio-Botanica Inc. - Blackmores Limited - ChromaDex, Inc. - Integrated BioPharma, Inc. - NBTY, Inc. - NaturaLife Asia Co., Ltd. - Nutraceutical International Corporation - Pharmavite LLC - Procter & Gamble Company - Ricola AG - Surya Herbal, Ltd. - The Himalaya Drug Company For more information visit http://www.researchandmarkets.com/research/mp...bal_market
NUTR: 24.49 (+0.25), PG: 80.95 (+0.29)
Global Paclitaxel Industry Report 2015
M2 - Fri Jan 09, 6:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/p5l2qc/global_paclitaxel) has announced the addition of the "Global Paclitaxel Industry Report 2015" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Paclitaxel market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Paclitaxel industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on Paclitaxel industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Paclitaxel industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: Chapter One Paclitaxel Industry Overview Chapter Two Paclitaxel International and China Market Analysis Chapter Three Paclitaxel Technical Data and Manufacturing Plants Analysis Chapter Four Paclitaxel Production by Regions by Technology by Applications Chapter Five Paclitaxel Manufacturing Process and Cost Structure Chapter Six 2009-2014 Paclitaxel Productions Supply Sales Demand Market Status and Forecast Chapter Seven Paclitaxel Key Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis Chapter Nine Paclitaxel Marketing Channels Analysis Chapter Ten 2015-2020 Paclitaxel Productions Supply Sales Demand Market Status and Forecast Chapter Eleven Paclitaxel Industry Development Proposals Chapter Twelve Paclitaxel New Project Investment Feasibility Analysis Chapter Thirteen Global and China Paclitaxel Industry Research Conclusions Companies Mentioned - Chongqin Meilian - Haiyao - Huiang - Jiangsu Yew Pharmaceutical Co, Ltd - Just From Natural - Sichuan Jiufeng - South Pharmaceutical - Taiji - Yunnan Hande Bio-Tech Co.,Ltd - Atlantis Bioactives - Indena - Mayne(Hospira) - Npi - Paxis(Integrated Biopharma) - Phyton - Phytogen - Roche Group - Weyerhaeser For more information visit http://www.researchandmarkets.com/research/p5...paclitaxel
